China Shineway Pharmaceutical Group Limited
CSWYF
$0.9398
$0.07378.51%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 889.79M | 925.89M | 858.00M | 863.51M | 833.86M |
| Total Receivables | 173.81M | 180.87M | 178.72M | 179.87M | 186.76M |
| Inventory | 111.41M | 115.93M | 114.26M | 114.99M | 126.60M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.01M | 3.14M | 13.90M | 13.99M | 2.81M |
| Total Current Assets | 1.18B | 1.23B | 1.16B | 1.17B | 1.15B |
|
|
|||||
| Total Current Assets | 1.18B | 1.23B | 1.16B | 1.17B | 1.15B |
| Net Property, Plant & Equipment | 167.06M | 173.84M | 166.95M | 168.02M | 169.98M |
| Long-term Investments | 22.74M | 23.66M | 22.84M | 22.98M | 23.40M |
| Goodwill | 22.74M | 23.66M | 22.84M | 22.98M | 23.40M |
| Total Other Intangibles | 3.20M | 3.33M | 3.82M | 3.84M | 4.62M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.70M | 4.89M | 1.71M | 1.72M | 2.15M |
| Total Assets | 1.38B | 1.43B | 1.36B | 1.37B | 1.35B |
|
|
|||||
| Total Accounts Payable | 55.21M | 57.45M | 63.40M | 63.80M | 68.37M |
| Total Accrued Expenses | 164.28M | 170.94M | 1.90M | 1.91M | 158.02M |
| Short-term Debt | 45.21M | 47.05M | 45.41M | 45.70M | 42.31M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.13M | 1.18M | 1.19M | 1.20M | 136.90K |
| Total Finance Division Other Current Liabilities | 69.83M | 72.66M | 223.17M | 224.60M | 74.38M |
| Total Other Current Liabilities | 69.83M | 72.66M | 223.17M | 224.60M | 74.38M |
| Total Current Liabilities | 335.66M | 349.28M | 335.07M | 337.22M | 343.22M |
|
|
|||||
| Total Current Liabilities | 335.66M | 349.28M | 335.07M | 337.22M | 343.22M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 45.21M | 47.05M | 45.41M | 45.70M | 42.31M |
| Capital Leases | 1.13M | 1.18M | 1.70M | 1.71M | 50.10K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 15.94M | 16.59M | 13.85M | 13.94M | 14.83M |
| Total Liabilities | 352.73M | 367.04M | 350.62M | 352.87M | 358.10M |
|
|
|||||
| Common Stock & APIC | 69.84M | 72.68M | 70.15M | 70.60M | 71.90M |
| Retained Earnings | 1.02B | 1.06B | 1.01B | 1.01B | 989.98M |
| Treasury Stock & Other | -67.80M | -70.55M | -68.10M | -68.54M | -69.79M |
| Total Common Equity | 1.02B | 1.06B | 1.01B | 1.02B | 992.08M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.02B | 1.06B | 1.01B | 1.02B | 992.08M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.02B | 1.06B | 1.01B | 1.02B | 992.08M |
|
|
|||||